I used to think 50% in range was doing pretty good! Instead of only making decisions when I tell my pump to do something (e.g. As of it is showing an estimated 5.8 A1C, and that is with 74% in range 75-160 mg/dL and only 8% hypoglycemia. 6 points to 6.0 from my last lab tested result of 6.6 from May 2016. I started using this system June 3, 2016, and according to the HbA1c estimate from my Dexcom reports I am down. Here’s what a rig like this looks like.Īll of these electronic bits fit snuggly inside a small digital camera bag.
Medtronic carelink usb stick plus#
I started off building an OpenAPS “rig” that used a Raspberry Pi 3 computer, my Dexcom CGM receiver, a Medtronic CareLink USB stick (for radio communication to my insulin pump) plus a 9000mAh external battery to power the Raspberry Pi. It’s not easy, but with the help of others, anyone motivated enough can do it. Through the community found on Gitter and Twitter we help each other go through the process of making our own DIY artificial pancreas. I have joined the now 100 diabetics (or parents/loved ones of) who have built/assembled their own open source artificial pancreas. Like I said, it is going to (soon) be a great time to be a diabetic. There are even still more, but those are some of my favorites. They hope to be able to offer a bi-hormonal insulin & glucagon system that will not adjust insulin delivery for high and low blood sugar, but infuse glucagon, which would raise blood sugar back to a safe level. And then there is my personal favorite (mostly because of the name) from Boston University based Beta Bionics and their iLet “fully integrated bionic pancreas”.
The Bigfoot system will use an iPhone connected to their pump device, in addition to using a Dexcom G5 for CGM.
Medtronic carelink usb stick trial#
Bigfoot Biomedical has announced the beginning of a closed loop clinical trial ( Closed Loop?). Medtronic has filed for Pre-Market Approval for their MiniMed 670g with the expectation of receiving a decision from the FDA in a year.
Insulin Pump and Continuos Glucose Monitor (CGM) makers are starting FDA clinical trials with the promise of releasing a commercial artificial pancreas in the next one to three years. It’s a great time (or soon to be a great time) to be a Type 1 Diabetic.
0 kommentar(er)
